Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
TRIPTANS3
Extra metadata
List of similar endpoints to
Triptan medication for migraine, min. 3 purchases
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 13460 | 11529 | 1931 |
| Unadjusted prevalence (%) | 5.18 | 7.85 | 1.71 |
| Mean age at first event (years) | 37.30 | 36.85 | 39.99 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.02 | 1.06 [0.81, 1.38] | 6.8e-1 | 184 |
| 15 years | 0.01 | 1.10 [0.83, 1.45] | 5.1e-1 | 111 |
| 5 years | 0.00 | 1.37 [0.88, 2.12] | 1.6e-1 | 25 |
| 1 year | - | - | - | - |
Index endpoint: TRIPTANS3 – Triptan medication for migraine, min. 3 purchases
GWS hits:
before Triptan medication for migraine, min. 3 purchases
after Triptan medication for migraine, min. 3 purchases
Loading survival analyses plot
Loading survival analyses table